FDMT: 4D Molecular Therapeutics Inc Broker Consensus Forecast
4D Molecular Therapeutics (FDMT) develops unique transport systems for delivering genetic material in the treatment of eye and heart pathologies using directed virus evolution methods. The price history on the GURU.Markets chart, where the indicator stands at 28.17, confirms the value of patent protection against competitors. Financial success is based on partnerships with behemoths such as Roche and insurance company payouts for innovative drugs.
Metric breakdowns and analytics for 4D Molecular Therapeutics Inc (FDMT)
- share price and expert price forecast:
- market capitalization information:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Debt to Equity Ratio 4D Molecular Therapeutics|FDMT - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio 4D Molecular Corp|FDMT - Company Aggregate Debts|Debts to Book Capitalization 4D Molecular Therapeutics Inc|FDMT - Company Long-Term Indebtedness|Company Short-Term Debts 4D Molecular Therapeutics|Quick Liquidity Indicator 4dmoleculartherapeutics.com
- business earnings and investment ratios data:
FDMT - Final Profit|Expected Profit 4D Molecular Therapeutics|FDMT - Price to Earnings Ratio|Future Price to Earnings 4DMT|FDMT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 4D Molecular Therapeutics Inc|FDMT - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) 4D Molecular Therapeutics|FDMT - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth 4dmoleculartherapeutics.com|FDMT - Net earnings per share growth this year|Expected earnings per share growth for next year 4D Molecular Therapeutics
General company analysis:FDMT 4dmoleculartherapeutics.com
Amid high volatility in the biotech sector, capital protection requires an analysis of market expectations regarding the future value of assets. Steady interest in the unique vector platform of 4D Molecular Therapeutics (FDMT) within closed clinical trials determines the average market target price, which aggregates expert forecasts on the business's fundamental value, helping investors differentiate real growth potential from speculative price overheating.
Competitors of 4D Molecular Therapeutics (FDMT)
TEM: Forecast Levels Chart|Analyst Consensus Forecast QGEN (Qiagen)|IONS: Broker Consensus Forecast|RGEN - Price Target Chart|Avidity Corp (RNA) - Consensus Target|CRSP (CRISPR Therapeutics AG) - Consensus Target|WGS: Analyst Forecast Prices|RARE (Ultragenyx) - Analyst Consensus Forecast|Broker Consensus Forecast BEAM (Beam Therapeutics Inc)|Price Target Chart Sarepta Therapeutics Inc (SRPT)|Twist Bioscience Corp - Broker Consensus Forecast|Analyst Consensus Forecast TXG (10x Genomics, Inc.)|Analyst Consensus Forecast intelliatx.com NTLA|Stoke Therapeutics, Inc. (STOK) - Broker Consensus Forecast|BLFS - Analyst Consensus Forecast|Broker Consensus Forecast Wave Life Sciences Corp|Consensus Target Maze Therapeutics Corp|SION - Fair Value Consensus|Price Target Chart PRME|Consensus Target TSHA (Taysha Gene Therapies, Inc.)|Price Target Chart QURE (uniQure NV)|MGTX: Average Forecast Price|REGENXBIO Corp - Price Target Chart|SLDB - Price Target Chart|OCGN - Analyst Consensus Forecast|Average Forecast Price PACB|Benitec Biopharma Inc (BNTC) - Analyst Consensus Forecast|Consensus Target DSGN|Consensus Target Rocket Corp (RCKT)|Analyst Consensus Forecast LXEO|Price Target Chart KRRO (korrobio.com)|Price Target Chart Editas Medicine EDIT|Analyst Consensus Forecast Silence Therapeutics PLC SLN|ProQR Therapeutics NV - Analyst Consensus Forecast|CDXS: Price Target Chart|Fair Value Consensus Sangamo Therapeutics SGMO|Consensus Target Nautilus Bio|MGX - Fair Value Consensus|Consensus Target Precision BioSciences Inc. (DTIL)|Analyst Forecast Prices Generation Bio Co.|Analyst Consensus Forecast Boundless Bio Inc (BOLD)|Fair Value Consensus Exicure|Analyst Consensus Forecast Imunon Inc IMNN|PHIO (RXi Pharmaceuticals) - Average Forecast Price|MBIO: Price Target Chart|Fair Value Consensus transcodetherapeutics.com RNAZ|Bionano Genomics (BNGO) - Analyst Consensus Forecast|APDN (Applied DNA Sciences) - Analyst Consensus Forecast|Price Target Chart BLUE|IPA - Forecast Levels Chart|Analyst Consensus Forecast Omega Therapeutics Inc (OMGA)|OMIC: Average Forecast Price|RGLS - Consensus Target|Syros Pharmaceuticals - Analyst Consensus Forecast|telesisbio.com (TBIO) - Consensus Target|TCON - Analyst Forecast Prices|Unity Biotechnology Inc. (UBX) - Analyst Consensus Forecast
